Clinical trial
Validation of a Tear-based Screening Assay for Breast Cancer as a Supplemental Tool to Screening Mammograms
NCT04928014 is registered in ClinicalTrials.gov with Namida Lab as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of a Tear-based Screening Assay for Breast Cancer as a Supplemental Tool to Screening Mammograms
- Lead sponsor
- Namida Lab
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2021
- Completion date
- December 31, 2025
- Enrollment
- 205 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, breast cancer female, health care acceptability, health care utilization, health knowledge, attitudes, practice, health personnel attitude, healthy